Member Info for itsallamess

Https://www.linkedin.com/posts/benjamin-mcleod_an-italian-non-profit-pulled-off-the-impossible-activity-7404870545697046528-sfpM?utm_source=share&utm_medium=member_android&rcm=ACoAAAK8t5ABw3aZE_8OX0kddq8_1GW3aGrkCas

Juhu responding positively to gaining FDA approval without big pharma 1 month ago.. is this a insight into why a deal hasnt been done..

The plan is to maximise profits for investors by not having BP take a massive cut?

Phase 3 trials of Traumakine (intravenous interferon beta-1a) were primarily funded through a combination of public grants and private investment led by its developer, Faron Pharmaceuticals.

The more time goes on, the more what Juhu said about getting best value for shareholders = not a partner now seems more likely IMO

I think they will do another share raise for phase 3.. whether its a public raise or private.. mixed with some ot g er type of investments.. but as time goes on the chance of a partnership seems unlikely... possibly due to faron not being offered what they want..

Or, the reason for the possible silence, is because they are in negotiations..?!?

But the git CFO selling would suggest nothing is happening soon..

Hope im wrong and a deal yo moon the price is in the workings..

But the kack of communication doesnt instill confidence

I think the CFO selling deserves some sort of explanation... the that email, the more Faron may respond, or at least not take the small investor for granted

Just sent a email to the contacts on faron website regarding dekkers sells.

Here the auto reply from one of the emails:

"Thank you for your message. I will be attending JPM Healthcare Week in San Francisco until 16 January, and responses may be delayed.

For urgent matters, please feel free to call or text me at +358 400 845 559."

https://faron.com/contact-information/

Good job greenman

The more I think about dekkers selling, the more irresponsible it seems.. it deosnt matter that its a small amount of shares.. he is in a position of authority and should have gave an explanation for selling if it was all innocent.

Everyone connected to faron knows the shareholders are looking for a pay day in whatever form that comes. If its a partner deal or a sell out or whatever.

Juhu and marku have hinted and strung us all along with their carrot on a stick.. at the very moment we are waiting for news on how phase 3 will be funded.. this idiot dekkers, the CFO for crying out loud, sells his shares..

The signal from the CFO tells everyone that he doesnt think anything announced in the next period of time will have a positive impact on the share price.. thats the message he just sent..

I cant write here how much this move from the newbie amature has made me angry! Justifiably so!

We need some news from Juhu 'soon' to coin his phrase before Faron becomes exactly the same as 99.9% of other AIM companies which are just funding a lifestyle...

Whatever way you look at it, it was irresponsible for dick to sell those shares..

He is the CFO chef financial officer of the company, been on the books 6 weeks and to sell cheap in his position has just undervalued everything the company has been working to..

More importantly he has just gave the biggest F U to shareholders!

Juhu need to sack him.. he ain't interested in faron or the shareholders! What an amature!

The CFO selling, is not a good sign. It looks like there isnt any deal to be done soon to send the SP flying, else why sell anything.

6 weeks on the Job as CFO and he just undermined the company share price with this amateur move!

Juhu should be livid right now!

This quite before the storm seems to be lasting years!

They are either working on finalizing a deal.. or they are working on raising funds...!?!

The fact that heights are choosing to accelerate their debt payments by taking shares now instead of waiting, could it mean they want to own the stock right now.

Heights have locked in a as low as the stock will ever be for them to buy.

Maybe they believe the stock is about to moon!

they want as many shares as possible now before the price gets even higher.

That would partway explian the nice price rise end of day!

Paying off nearly 850k of debt by issuing treasury shares to Heights Capital..

Seems the share price likes it!

Like making a extra payment from what they still owe

Deos juhu want a deal with gilead?

Just two weeks ago , December 12, 2025, Gilead had to discontinue a major Phase 3 study (STAR-221) for their drug zimberelimab because it wasn't performing well enough.

​Gilead will now be highly motivated to find a way to make zimberelimab work. If bex can fix this, ie make tumors sensitive to zimberelimab again, it saves Gilead's multi-billion dollar investment!

Https://www.linkedin.com/posts/petri-bono-68655a28_faron-announces-strategic-collaboration-with-activity-7408775121814949888-nLtd?utm_source=share&utm_medium=member_android&rcm=ACoAAAK8t5ABw3aZE_8OX0kddq8_1GW3aGrkCas

The only thing that will lift off the share price is news of how they plan to fund phase 3 and now blaze.

Its clear the markets wont respond to any other news at this stage of the game..

Won't even bother reading chat gpt.. AI will lie to you to tell you what you want to hear!

Won't even bother reading chat gpt.. AI will lie to you to tell you what you want to hear!

New trail announced.. early stages.. but who is funded this.

Not quite over reach yet, but if funding doesnt come from a BP then from who?

Are they spinning things out to get registered for the big a EU money?

If theres a possibility to do this without big pharma taking a almighty slice then thats the direction they will go..

Past track record with taumakine.. they wanted to do it all themselves!

If the EU is keen for the EU to succeed.. then why let faron slip through their fingers..

Juhu already has spoke about getting the best deal for investors.. suggesting not taking any deal.. even if it takes longer..

Funding for phase 3 via the EU, realeases them from a BP taking the lionshare of faron.. leaving the shareholders to benefit to the max.

Https://healthcarelifesciences.bakermckenzie.com/2025/12/19/eu-biotech-act-unveiled-commissions-proposal-to-turn-europe-into-a-biotech-powerhouse/?hl=en-GB

​ "Designed to bridge the current funding gap for biotech companies, especially at the scale-up and late-stage development phases, the Pilot brings together public and private capital..."

Phase 3 would be late stage development!